Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Eur J Heart Fail. 2018 Feb;20(2):295-303. doi: 10.1002/ejhf.901. Epub 2017 Sep 4.
Hospitalizations for heart failure (HF) are common and are associated with significant morbidity, mortality and cost. However, precipitating factors leading to HF hospitalization and their importance with respect to subsequent outcomes are not well understood.
The symptoms and signs present at admission and investigator-identified factors thought to have contributed to the first adjudicated HF hospitalization in the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programme were prospectively collected and stratified by ejection fraction (EF). Potential precipitants were collected using a specifically designed case report form and categorized according to the presence of cardiovascular (CV), non-CV and unknown factors. Associations between these factors and subsequent rehospitalization and mortality rates were examined. Of 1668 patients who experienced HF hospitalization, 1152 had reduced EF (≤40%, HFrEF) and 516 had preserved EF (HFpEF). Overall, 54% had CV, 32% had non-CV and 14% had unknown factors thought to have precipitated HF, with similar proportions in the HFrEF and HFpEF groups. The most common precipitants were arrhythmia (15%), other non-CV factors (11%) and respiratory infection (10%). Subsequent CV readmission rates were highest in those whose initial HF hospitalization was precipitated by CV factors. However, mortality rates were similar among patients with any of the three categories of precipitating factors. Results were similar in HFrEF and HFpEF.
Among chronic HF patients hospitalized for decompensation, the investigator-reported precipitating factor was not associated with the subsequent mortality rate, but was associated with type of readmission: readmissions for CV reasons were more likely when the index precipitant was CV.
心力衰竭(HF)住院治疗很常见,与较高的发病率、死亡率和医疗费用相关。然而,导致 HF 住院的诱发因素及其对后续结局的重要性尚不清楚。
在坎地沙坦心力衰竭评估减少死亡率和发病率(CHARM)研究中,前瞻性地收集了入院时的症状和体征以及研究者确定的可能导致首次心力衰竭住院的因素,并按射血分数(EF)进行分层。使用专门设计的病例报告表收集潜在的诱发因素,并根据心血管(CV)、非 CV 和未知因素的存在进行分类。研究了这些因素与随后的再住院率和死亡率之间的关系。在 1668 例经历 HF 住院治疗的患者中,1152 例患者射血分数降低(≤40%,HFrEF),516 例患者射血分数保留(HFpEF)。总的来说,54%的患者有 CV 因素,32%的患者有非 CV 因素,14%的患者有未知因素被认为是 HF 的诱发因素,HFrEF 和 HFpEF 两组的比例相似。最常见的诱发因素是心律失常(15%)、其他非 CV 因素(11%)和呼吸道感染(10%)。最初 HF 住院治疗由 CV 因素诱发的患者,随后 CV 再入院率最高。然而,在有任何三类诱发因素的患者中,死亡率相似。HFrEF 和 HFpEF 中的结果相似。
在因失代偿而住院的慢性 HF 患者中,研究者报告的诱发因素与随后的死亡率无关,但与再入院类型有关:当指数诱发因素为 CV 时,更有可能因 CV 原因再次入院。